Author: faroson.au

• TERMS OF USE

  by: faroson.au uncategorized 0 2020-08-13 09:37:04

  Thank you for visiting Faroson’s website. All information posted on the site is based on the latest research and national treatment standards, and have been written or reviewed and approved by Faroson or health professionals unless otherwise specified. By accessing, browsing and/or using webpages or other digital content in this site, you accept, without limitation […]

  Read more

• SOCIAL MEDIA POLICY

  by: faroson.au uncategorized 0 2020-08-13 09:36:36

  SOCIAL MEDIA POLICY Our rules governing posting on Faroson’s publicly facing social media sites and pages, including Facebook. BY POSTING ON ANY FAROSON SOCIAL MEDIA SITE YOU AGREE TO THESE TERMS. Faroson has opened publicly facing pages on social media sites for viewing content and/or videos and posting comments about FAROSON. These social media sites […]

  Read more

• PRIVACY POLICIES

  by: faroson.au uncategorized 0 2020-08-13 09:35:46

  Official privacy policy, notice of privacy practices and information about how we protect the information entered into this website. PERSONAL INFORMATION. A visitor can access and browse our entire site at any time without providing any personal information. We do not collect information that would personally identify you unless you choose to provide it. In […]

  Read more
• 

  What You Need to Know about Glucosamine – Faroson Joints Care 9 in 1

  by: faroson.au NEWS 0 2020-08-13 03:28:36

  What is Glucosamine? Glucosamine is a compound that is naturally made in humans as part of the structure of cartilage. In the body, it is a naturally occurring amino sugar that is used to create complex proteins. Some of these complex proteins are the major components of the cartilage extracellular matrix. This complex connective tissue […]

  Read more
• 

  Silymarin in the prevention and treatment of liver diseases and primary liver cancer – Faroson Liver 9

  by: faroson.au NEWS 0 2020-08-13 03:27:41

  In chronic liver diseases caused by oxidative stress (alcoholic and non-alcoholic fatty liver diseases, drug- and chemical-induced hepatic toxicity), the antioxidant medicines such as silymarin can have beneficial effect. Liver cirrhosis, non-alcoholic fatty liver and steatohepatitis are risk factors for hepatocellular carcinoma (HCC). Insulin resistance and oxidative stress are the major pathogenetic mechanisms leading the […]

  Read more